Non invasive biosensors market

Non-invasive Biosensors Market, by Technology (Optical, Transdermal, Thermal, and Others), by Product Type (Glucose Monitors, Blood Analytes Monitors, Breathalyzers, and Others), by End User (Hospitals, Diagnostic Lab, Homecare Settings, and Others) and by Region - Global Forecast to 2026

  • May 2018
  • CMI1704
  • 173 Pages
  • Excel & Pdf
  • Medical Devices

Non-Invasive Biosensor Market - Insights

Biosensors are electronic devices, which uses biological molecules such as enzymes, proteins, or antibodies for the detection and measurement of any substance or chemical. Non-invasive biomarkers are advanced diagnostic devices, which do not require incision or insertion of instruments/devices in the body. There is no contact with mucosa, or skin break, or internal body cavity for diagnosis. Non-invasive biosensor mainly uses tears, saliva, and sweat for the analysis and diagnosis of various diseases. There are few non-invasive biosensor devices available in market, however, a robust pipeline of novel non-biosensors is under development and under clinical trial. Key players in the market are focusing on research and development activities for development of novel non-invasive biosensors and to launch it in market.

Increasing approval for non-invasive biosensor devices is expected to drive growth of the global market

In 2016, Nemaura Medical, Inc. received CE approval in the European Union for its sugarBEAT, a minimally invasive wireless continuous glucose monitor. SugarBEAT CGM system is available in the form of sensor patch and provides glucose readings on a standalone reader, smart watch or smart phone app via Bluetooth. In March 2018, Nemaura Medical, Inc. expanded its manufacturing facilities for large scale production of its new SugarBEAT CGM system. The company is expected to launch its product in the U.K. in the near future. The approval and launche of such novel devices is expected to create a lucrative environment for growth of global non-invasive biosensor market in the near future.

The global non-invasive biosensor market was valued at US$ 2.7 Bn in 2017 and is expected to witness a CAGR of 12.1% over the forecast period (2018–2026).

Figure 1. Global Non-invasive Biosensor Market Size (US$ Bn), By Region, 2017

Source: Coherent Market Insights Analysis (2017)

Increasing research and development and robust pipeline of novel non-invasive biosensors is expected to drive growth of the non-invasive biosensor market

Increasing research and development and a robust pipeline of novel non-invasive biosensors is expected to drive growth of the global non-invasive biosensor market in the near future. For instance, MediWise Ltd.—a U.K.-based company—has its product GlucoWise in clinical trial. GlucoWise is a non-invasive glucose monitor device and is expected to be launched in 2018. In 2017, researchers from University of Cincinnati developed a non-invasive biosensor, which uses chemical stimulant to produce sweat and uses sweat to monitor biometrics.

Increasing prevalence of diabetes is expected to increase demand for non-invasive biosensors for diagnosis

According to World Health Organization (WHO), 2014, around 8.5% of adults aged 18 and above accounting for 422 million adults were suffering from diabetes worldwide. According to National Diabetes Statistics Report 2017 published by Centers of Disease Control and Prevention (CDC), around 9.4% of the population in the U.S., which includes all age groups i.e., pediatric, adults, and geriatric population accounting for 30.3 million people are suffering from diabetes whereas 33.9% are diagnosed with pre-diabetes. Increasing prevalence of diabetes is expected to increase demand for novel diagnostic devices such as non-invasive glucometer and this is expected to drive growth of global non- invasive biosensor market.

Furthermore, key players in the market are participating in various conference and symposium, in order to showcase their novel non-invasive biosensors. For instance, in 2017, Integrity Applications Inc. exhibited its new GlucoTrack at American Diabetes Association’s 77th Scientific Sessions held at San Diego, U.S.

Key players operating in the non-invasive biosensors market include Nemaura Medical, Inc., MediWise Ltd., Integrity Applications Inc., OrSense, Medtronic Plc, GE Healthcare, Philips Healthcare, Akers Biosciences, Inc. and Abbott Laboratories.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Technology
      • Market Snippet, By Product Type
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Recent Product Approval/Launch
    • Pipeline Analysis
    • Regulatory Scenario
    • Reimbursement Scenario
    • PEST Analysis
    • PORTER Analysis
    • Epidemiology
  4. Global Non-Invasive Biosensors Market, By Technology, 2016–2026 (US$ Bn)
    • Introduction
      • Market Share Analysis, 2017 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017–2026
      • Segment Trends
    • Optical
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Bn)
    • Transdermal
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Bn)
    • Thermal
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Bn)
  5. Global Non-Invasive Biosensors Market, By Product Type, 2016–2026 (US$ Bn)
    • Introduction
      • Market Share Analysis, 2017 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017–2026
      • Segment Trends
    • Glucose monitors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Bn)
    • Blood Analytes Monitors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Bn)
    • Breathalyzers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Bn)
  6. Global Non-Invasive Biosensors Market, By End User, 2016–2026 (US$ Bn)
    • Introduction
      • Market Share Analysis, 2017 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017–2026
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Bn)
    • Diagnostic Lab
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Bn)
    • Homecare Settings
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Bn)
  7. Global Non-Invasive Biosensors Market, By Region, 2016–2026 (US$ Bn)
    • Introduction
      • Market Share Analysis, By Region, 2017 and 2026 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Introduction
      • Market Size and Forecast, By Technology, 2016–2026 (US$ Bn)
      • Market Size and Forecast, By Product Type, 2016–2026 (US$ Bn)
      • Market Size and Forecast, By End User, 2016–2026 (US$ Bn)
      • Market Size and Forecast, By Country, 2016–2026 (US$ Bn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, By Technology, 2016–2026 (US$ Bn)
      • Market Size and Forecast, By Product Type, 2016–2026 (US$ Bn)
      • Market Size and Forecast, By End User, 2016–2026 (US$ Bn)
      • Market Size and Forecast, By Country, 2016–2026 (US$ Bn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, By Technology, 2016–2026 (US$ Bn)
      • Market Size and Forecast, By Product Type, 2016–2026 (US$ Bn)
      • Market Size and Forecast, By End User, 2016–2026 (US$ Bn)
      • Market Size and Forecast, By Country, 2016–2026 (US$ Bn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, By Technology, 2016–2026 (US$ Bn)
      • Market Size and Forecast, By Product Type, 2016–2026 (US$ Bn)
      • Market Size and Forecast, By End User, 2016–2026 (US$ Bn)
      • Market Size and Forecast, By Country, 2016–2026 (US$ Bn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of APAC Japan
        • Australia
    • Middle East
      • Introduction
      • Market Size and Forecast, By Technology, 2016–2026 (US$ Bn)
      • Market Size and Forecast, By Product Type, 2016–2026 (US$ Bn)
      • Market Size and Forecast, By End User, 2016–2026 (US$ Bn)
      • Market Size and Forecast, By Country, 2016–2026 (US$ Bn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, By Technology, 2016–2026 (US$ Bn)
      • Market Size and Forecast, By Product Type, 2016–2026 (US$ Bn)
      • Market Size and Forecast, By End User, 2016–2026 (US$ Bn)
      • Market Size and Forecast, By Country, 2016–2026 (US$ Bn)
        • Central Africa
        • South Africa
        • North Africa
  8. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • Nemaura Medical, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • MediWise Ltd.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Integrity Applications Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • OrSense
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Medtronic Plc
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • GE Healthcare
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Philips Healthcare
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Akers Biosciences, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Abbott Laboratories
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 42 market data tables and 38 figures on “Non-Invasive Biosensors Market - Global forecast to 2026”.

N/A
- Frequently Asked Questions -

What are the growth estimates for non-invasive biosensors market till 2026?

The global non-invasive biosensors market is estimated to surpass US$ 7.5 Billion by 2026

Which are the prominent non-invasive biosensors market players across the globe?

Major players operating in the global non-invasive biosensors market include Nemaura Medical, Inc., MediWise Ltd., Integrity Applications Inc., OrSense, Medtronic Plc, GE Healthcare, Philips Healthcare, Akers Biosciences, Inc., and Abbott Laboratories.

Why Europe is dominating the non-invasive biosensors market?

Europe is dominating the non-invasive biosensors market due to increasing approvals of novel non-invasive biosensors by European Union.

What are the key factors driving growth of the non-invasive biosensors market?

Increasing approval for novel non-invasive biosensors is one of the major factors that is expected to propel growth of the market over the forecast period.

What is the Compound Annual Growth Rate (CAGR) of the non-invasive biosensors market for next 8 years?

The global non-invasive biosensors market is estimated to exhibit a CAGR of 12.1% over the forecast period.

Which region is dominating the non-invasive biosensors market growth?

Among regions, Europe is expected to witness significant growth over the forecast period.
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.